EUVIMEDEUVIMED entdecken
Multizentrische Studie

SQ HDM Sublingual Immunotherapy Tablet for the Treatment of HDM Allergic Rhinitis and Asthma Improves Subjective Sleepiness and Insomnia: An Exploratory Analysis of the Real-life CARIOCA Study

D Jaffuel, E Serrano, C Leroyer, A Chartier, P Demoly

Journal of Investigational Allergy and Clinical Immunology · 2024

DOI: 10.18176/jiaci.0934 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Journal of Investigational Allergy and Clinical Immunology, 2024. Verfasst von D Jaffuel und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Respiratory Diseases, Hôpital Arnaud de Villeneuve, University Hospital of Montpellier, France. Hauptthemen laut MEDLINE: Sublingual Immunotherapy, Sleep Initiation and Maintenance Disorders, Asthma, Pyroglyphidae. Die Arbeit wurde bisher 2-mal zitiert (Crossref).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Knowledge of the effectiveness of house dust mite (HDM) sublingual immunotherapy (SLIT) in allergic rhinitis (AR) and asthma-associated sleep disorders remains incomplete. A noninterventional study was conducted to assess the effect of the standardized quality (SQ) HDM SLIT tablet on safety and symptoms in adults with respiratory allergies caused by HDM. The study also assessed the status of insomnia and daytime sleepiness in patients with AR and/or asthma-associated sleep disorders treated with the SQ HDM SLIT tablet.

Methods

This was a 12-month multicenter, longitudinal, and prospective study. Participants started the SQ HDM SLIT tablet for moderateto-severe HDM-induced AR that was persistent despite the use of symptom-relieving medication or HDM-induced asthma-associated sleep disorders that were not well controlled with inhaled corticosteroids and were associated with mild-to-severe HDM-induced AR. Sleep symptoms were measured using the Insomnia Severity Index (ISI) questionnaire and the Epworth Sleepiness Scale (ESS).

Results

A total of 1526 adult patients were enrolled, and 1483 were eventually included in the analysis. At baseline, 41.5% of patients reported sleep disorders; of these, 77.0% had insomnia and 28.9% experienced excessive daytime sleepiness. Insomnia was significantly more frequent among patients with uncontrolled AR (83.1%) than among those with controlled AR (52.6%) (P

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Sublingual ImmunotherapySleep Initiation and Maintenance DisordersAsthmaPyroglyphidaeRhinitis, AllergicTabletsHumansMaleFemaleAdultMiddle AgedAnimalsProspective StudiesAntigens, DermatophagoidesTreatment OutcomeLongitudinal StudiesSleepinessAllergensYoung Adult

Stichwörter der Autor:innen

Allergen immunotherapyAllergic asthmaAllergic rhinitisControlHouse dust miteSleep

Substanzen

TabletsAntigens, DermatophagoidesAllergens

Autor:innen und Institutionen

  • Department of Respiratory Diseases, Hôpital Arnaud de Villeneuve, University Hospital of Montpellier, France.
  • Inserm U1046 - CNRS 9214 - University of Montpellier, Montpellier, France.
  • Department of ENT and Head and Neck Surgery, Hôpital Larrey, University Hospital of Toulouse, Toulouse, France.
  • Clinical Investigation Center, CIC Inserm 1412, Hôpital Cavale Blanche, University Hospital of Brest, Brest, France.
  • Medical Department, ALK, Courbevoie, France.
  • IDESP, UMR UA11 Univ Montpellier - INSERM, Montpellier, France.

Zitieren

APA

Jaffuel, D., Serrano, E., Leroyer, C., Chartier, A., & Demoly, P. (2024). SQ HDM Sublingual Immunotherapy Tablet for the Treatment of HDM Allergic Rhinitis and Asthma Improves Subjective Sleepiness and Insomnia: An Exploratory Analysis of the Real-life CARIOCA Study. Journal of Investigational Allergy and Clinical Immunology. https://doi.org/10.18176/jiaci.0934

Vancouver

Jaffuel D, Serrano E, Leroyer C, Chartier A, Demoly P. SQ HDM Sublingual Immunotherapy Tablet for the Treatment of HDM Allergic Rhinitis and Asthma Improves Subjective Sleepiness and Insomnia: An Exploratory Analysis of the Real-life CARIOCA Study. Journal of Investigational Allergy and Clinical Immunology. 2024. doi:10.18176/jiaci.0934

BibTeX
@article{Jaffuel2024,
  author = {Jaffuel, D and Serrano, E and Leroyer, C and Chartier, A and Demoly, P},
  title = {SQ HDM Sublingual Immunotherapy Tablet for the Treatment of HDM Allergic Rhinitis and Asthma Improves Subjective Sleepiness and Insomnia: An Exploratory Analysis of the Real-life CARIOCA Study},
  journal = {Journal of Investigational Allergy and Clinical Immunology},
  year = {2024},
  doi = {10.18176/jiaci.0934}
}
Kostenlos starten →